Crinetics Pharmaceuticals Inc Long-term Investment Intensity
Crinetics Pharmaceuticals Inc long-term investment intensity. Crinetics Pharmaceuticals Inc (CRNX) has a Long-term Investment Intensity of 0.1% as of December 2023. Long-term investments of $470.00K represent 0.1% of total assets of $635.35 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See CRNX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Crinetics Pharmaceuticals Inc (2021–2023)
Long-term investment intensity of Crinetics Pharmaceuticals Inc from 2021 to 2023. This chart shows how Crinetics Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2021 to 2023. As of December 2023, the intensity stands at 0.1%, reflecting long-term investments of $470.00K against total assets of $635.35 Million USD. See operational self-sufficiency of Crinetics Pharmaceuticals Inc to measure how many days the company can operate on defensive assets alone.
Crinetics Pharmaceuticals Inc Long-term Investment Intensity by Year (2021–2023)
Crinetics Pharmaceuticals Inc long-term investment intensity by year from 2021 to 2023. The table below presents the year-by-year Long-term Investment Intensity for Crinetics Pharmaceuticals Inc from 2021 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Crinetics Pharmaceuticals Inc's balance sheet.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.1% | $470.00K | $635.35 Million | ▼ -0.2 pp |
| 2021 | 0.3% | $1.01 Million | $351.01 Million | — |